RBI
CORT icon

Raiffeisen Bank International’s Corcept Therapeutics CORT Stock Holding History

Raiffeisen Bank International’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,000
Closed -$145K – 832
2025
Q2 		$147K Hold
2,000
– – ﹤0.01% 448
2025
Q1 		$228K Hold
2,000
– – ﹤0.01% 424
2024
Q4 		$104K Buy
+2,000
New +$105K ﹤0.01% 494

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Raiffeisen Bank International's CORT Position: Q3 2025 in Review

Raiffeisen Bank International sold out of Corcept Therapeutics (CORT) in Q3 2025, closing a stake of 2,000 shares — an estimated $145K sold.

Raiffeisen Bank International first reported a position in CORT in Q4 2024 and held it in 3 quarters. The position peaked at $228K in Q1 2025. 429 funds tracked by Wall St. Rank hold CORT as of Q3 2025.

  • Raiffeisen Bank International reported no remaining Corcept Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Raiffeisen Bank International sold 2,000 Corcept Therapeutics shares in Q3 2025, an estimated $145K.
  • Raiffeisen Bank International first reported a position in Corcept Therapeutics in Q4 2024 and held it in 3 quarters.
  • Raiffeisen Bank International's Corcept Therapeutics position peaked at $228K in Q1 2025.
  • 429 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2025.

Based on Raiffeisen Bank International's 13F filing for Q3 2025, filed 10 Nov 2025.